I den samlede behandlingspopulation, som omfattede både influenza- positive – og negative personer, reduceredes den primære effekt proportionalt med antallet af ikke smittede personer (ITT).
In the pooled treatment study population, which included both influenza-positive and -negative subjects (ITT), primary efficacy was reduced proportional to the number of influenza-negative individuals.